Keyuan News
19
2025-11
According to the "Measures for Public Participation in Environmental Impact Assessment" (Ministry of Ecology and Environment Order No. 4), "Article 20: Before submitting the environmental impact report for approval to the ecological and environmental authorities, the project proponent shall publicly disclose the full text of the draft environmental impact report and the public participation statement via an online platform."
2025-11-19
18
2025-11
Shandong Keyuan Pharmaceutical Co., Ltd. has completed the Environmental Impact Assessment Report (Draft for Comments) of its Intelligent Pilot-Scale Platform Project for Specialty and Innovative Active Pharmaceutical Ingredients.
2025-11-18
18
2025-11
On November 18, the award ceremony for the "2024-2025 Family Essential Medicines List Brand" event—hosted by Family Doctor Online—concluded successfully during the Autumn Nanjing exhibition of the 91st National Pharmaceutical Fair. Recognized as an authoritative benchmark in the field of family health and medicine, the event is hailed within the industry as the "leading indicator for essential healthcare products families should consider." All brands selected for the list underwent rigorous multi-stage screening processes, including eligibility checks, market research, public voting, and expert evaluations, ensuring both the quality and reputation of the featured products while also aiming to provide consumers with a scientifically sound guide for building their household medicine kits.
2025-11-18
09
2025-10
From October 7 to 8, Shandong Keyuan Pharmaceutical Co., Ltd. (stock code: 301281.SZ) held a grand marketing-focused work conference. The meeting was themed "Charge Full Speed into the Fourth Quarter—Win the Closing Battle!" and featured a comprehensive review of the company's performance from January to September, along with strategic planning for the fourth quarter and beyond, ensuring the successful achievement of this year's business objectives. Chairman and President Gao Chunpo, Executive Vice President Ren Guangqiang, heads of various departmental centers, plant directors, and all members of the Marketing Center attended the event.
2025-10-09
28
2025-09
On September 28, the grand inauguration ceremony for the AI+Computing Power Intelligent Factory of Linuo Pharmaceutical Injection Project, a wholly-owned subsidiary of Keyuan Pharmaceutical (stock code: 301281.SZ), was held solemnly in Jinan. Over 100 guests attended the event, including representatives from Jinan Municipal Market Supervision Administration, Municipal Bureau of Industry and Information Technology, Municipal Bureau of Commerce, Municipal Bureau of Science and Technology, as well as officials from Licheng District Government and local subdistrict offices. Also present were renowned experts and scholars from the pharmaceutical industry, along with representatives from upstream and downstream partner companies, financial institutions, and media outlets—everyone gathered to witness Keyuan Pharmaceutical & Linuo Pharmaceutical’s groundbreaking achievement in the field of intelligent manufacturing for injectables.
2025-09-28
20
2025-07
To comprehensively summarize the achievements and shortcomings of the first half of the year, deeply analyze industry development trends, and outline key tasks and future strategic plans for the second half, Keyuan Pharmaceutical grandly held its semi-annual management cadre review meeting on July 19, rallying collective consensus and committing fully to achieving the annual goals.
2025-07-20
11
2025-07
To further enhance the company's operational management capabilities and strengthen the team's understanding and application of the Lean Management System, Keyuan Pharmaceutical (stock code: 301281.SZ) recently invited Liu Xingcun, Vice President of the Group and Dean of the Digital Intelligence Application Research Institute, to deliver a specialized training session themed "Corporate Business Strategy Management." This initiative aims to help team members deepen their insight into the company's business logic, master the methodology and relevant tools for strategy management, and ultimately inject new momentum into the company's high-quality development.
2025-07-11
01
2025-07
This exercise was conducted under the principles of "realistic simulation and practical effectiveness," replicating a scenario where a hazardous chemical leak triggers a fire accident. Lin Yan, EHS Vice President, along with employees from all departments across various plants, actively participated. All participants worked together seamlessly, successfully completing the exercise mission.
2025-07-01
24
2025-06
On the eve of the exhibition opening, Gao Chunpo, Chairman and President of Keyuan Pharmaceutical, personally led the international marketing team to host an international VIP client symposium, fostering in-depth communication and exchanges with partners from around the globe.
2025-06-24
21
2025-06
This competition featured two events: men's singles and women's singles, both of which attracted a large number of participants eager to compete. At the venue, athletes wholeheartedly embraced the competitive spirit of "Friendship First, Competition Second," engaging in lively exchanges and friendly rivalry as they expertly wielded their rackets. Throughout the matches, countless thrilling reversals, dazzling smashes, spectacular fast breaks, and exhilarating rallies unfolded one after another, vividly showcasing the players' passion and strategic brilliance.
2025-06-21